Free Trial
LON:RIII

Rights & Issues Investment Trust (RIII) Share Price, News & Analysis

Rights & Issues Investment Trust logo
GBX 2,170 -25.00 (-1.14%)
As of 08/1/2025 12:10 PM Eastern

About Rights & Issues Investment Trust Stock (LON:RIII)

Key Stats

Today's Range
2,170
2,199.40
50-Day Range
2,035.69
2,254.88
52-Week Range
1,670
2,500
Volume
3,593 shs
Average Volume
4,449 shs
Market Capitalization
£104.90 million
P/E Ratio
6.90
Dividend Yield
1.98%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rights & Issues Investment Trust and its competitors with MarketBeat's FREE daily newsletter.

RIII Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Civil Rights activist Garvey Crossword Clue
See More Headlines

RIII Stock Analysis - Frequently Asked Questions

Rights & Issues Investment Trust's stock was trading at GBX 2,378.49 at the beginning of 2025. Since then, RIII stock has decreased by 8.8% and is now trading at GBX 2,170.

Rights & Issues Investment Trust (LON:RIII) issued its quarterly earnings data on Friday, February, 21st. The company reported $42.10 earnings per share for the quarter. Rights & Issues Investment Trust had a trailing twelve-month return on equity of 12.60% and a net margin of 93.27%.

Shares of RIII stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rights & Issues Investment Trust investors own include Milestone Pharmaceuticals (MIST), Ovintiv (OVV), SIG (SHI), Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), Affiliated Managers Group (AMG) and Aravive (ARAV).

Company Calendar

Last Earnings
2/21/2025
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:RIII
CIK
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 314.53
Trailing P/E Ratio
6.90
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£15.28 million
Net Margins
93.27%
Pretax Margin
N/A
Return on Equity
12.60%
Return on Assets
1.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.38
Quick Ratio
60.63

Sales & Book Value

Annual Sales
£16.38 million
Price / Sales
6.40
Cash Flow
GBX 179.23 per share
Price / Cash Flow
12.11
Book Value
GBX 2,584.15 per share
Price / Book
0.84

Miscellaneous

Outstanding Shares
4,834,231
Free Float
N/A
Market Cap
£104.90 million
Optionable
Not Optionable
Beta
0.74
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (LON:RIII) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners